{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:37:50Z","timestamp":1792427870088,"version":"4.5.0"},"reference-count":25,"publisher":"Pacini Editore","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Otorhinolaryngol Ital"],"DOI":"10.14639\/0392-100x-n2841","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T08:04:41Z","timestamp":1742285081000},"page":"28-38","source":"Crossref","is-referenced-by-count":2,"title":["Role of body mass index as a predictor of dupilumab efficacy in patients with severe chronic rhinosinusitis with nasal polyps"],"prefix":"10.14639","volume":"45","author":[{"given":"Letizia","family":"Nitro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"De Corso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Borin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto Maria","family":"Saibene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Arnone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ferella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Gramellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cantiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"De Maio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Spanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto Giulio","family":"Dragonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Felisati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Pipolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"20340","published-online":{"date-parts":[[2025,1]]},"reference":[{"key":"10.14639\/0392-100X-N2841_ref1","doi-asserted-by":"crossref","unstructured":"Fokkens WJ, Lund VJ, Hopkins C, et al. Executive summary of EPOS 2020 including integrated care pathways. Rhinology 2020;58:82-111. https:\/\/doi.org\/10.4193\/Rhin20.601","DOI":"10.4193\/Rhin20.601"},{"key":"10.14639\/0392-100X-N2841_ref2","doi-asserted-by":"crossref","unstructured":"Kato A. Immunopathology of chronic rhinosinusitis. Allergol Int 2015;64:121-130. https:\/\/doi.org\/10.1016\/j.alit.2014.12.006","DOI":"10.1016\/j.alit.2014.12.006"},{"key":"10.14639\/0392-100X-N2841_ref3","doi-asserted-by":"crossref","unstructured":"Zhang N, Van Zele T, Perez-Novo C, et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol 2008;122:961-968. https:\/\/doi.org\/10.1016\/j.jaci.2008.07.008","DOI":"10.1016\/j.jaci.2008.07.008"},{"key":"10.14639\/0392-100X-N2841_ref4","doi-asserted-by":"crossref","unstructured":"Lin H, Li Z, Lin D, et al. Role of NLRP3 inflammasome in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps. Inflammation 2016;39:2045-2052. https:\/\/doi.org\/10.1007\/s10753-016-0442-z","DOI":"10.1007\/s10753-016-0442-z"},{"key":"10.14639\/0392-100X-N2841_ref5","unstructured":"World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:I-XII, 1-253."},{"key":"10.14639\/0392-100X-N2841_ref6","unstructured":"Bastard J-P, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006;17:4-12."},{"key":"10.14639\/0392-100X-N2841_ref7","doi-asserted-by":"crossref","unstructured":"Engin A. The pathogenesis of obesity-associated adipose tissue inflammation. Adv Exp Med Biol 2017;960:221-245. https:\/\/doi.org\/10.1007\/978-3-319-48382-5_9","DOI":"10.1007\/978-3-319-48382-5_9"},{"key":"10.14639\/0392-100X-N2841_ref8","doi-asserted-by":"crossref","unstructured":"Cancello R, Cl\u00e9ment K. Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG 2006;113:1141-1147. https:\/\/doi.org\/10.1111\/j.1471-0528.2006.01004.x","DOI":"10.1111\/j.1471-0528.2006.01004.x"},{"key":"10.14639\/0392-100X-N2841_ref9","doi-asserted-by":"crossref","unstructured":"Taildeman J, Demetter P, Rottiers I, et al. Identification of the nasal mucosa as a new target for leptin action. Histopathology 2010;56:789-798. https:\/\/doi.org\/10.1111\/j.1365-2559.2010.03552.x","DOI":"10.1111\/j.1365-2559.2010.03552.x"},{"key":"10.14639\/0392-100X-N2841_ref10","doi-asserted-by":"crossref","unstructured":"Vandanmagsar B, Youm YH, Ravussin A, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 201;17:179-188. https:\/\/doi.org\/10.1038\/nm.2279","DOI":"10.1038\/nm.2279"},{"key":"10.14639\/0392-100X-N2841_ref11","doi-asserted-by":"crossref","unstructured":"Nitro L, Bulfamante AM, Rosso C, et al. Adverse effects of dupilumab in chronic rhinosinusitis with nasal polyps. Case report and narrative review. Acta Otorhinolaryngol Ital 2022;42:199-204. https:\/\/doi.org\/10.14639\/0392-100X-N1911","DOI":"10.14639\/0392-100X-N1911"},{"key":"10.14639\/0392-100X-N2841_ref12","doi-asserted-by":"crossref","unstructured":"Wenzel S, Ford L, Pearlman D, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 2013;368:2455-2466. https:\/\/doi.org\/10.1056\/NEJMoa1304048","DOI":"10.1056\/NEJMoa1304048"},{"key":"10.14639\/0392-100X-N2841_ref13","doi-asserted-by":"crossref","unstructured":"Bachert C, Mannent L, Naclerio RM, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA 2016;315:469-479. https:\/\/doi.org\/10.1001\/jama.2015.19330","DOI":"10.1001\/jama.2015.19330"},{"key":"10.14639\/0392-100X-N2841_ref14","doi-asserted-by":"crossref","unstructured":"Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet 2019;394:1638-1650. https:\/\/doi.org\/10.1016\/S0140-6736(19)31881-1","DOI":"10.1016\/S0140-6736(19)31881-1"},{"key":"10.14639\/0392-100X-N2841_ref15","doi-asserted-by":"crossref","unstructured":"De Corso E, Settimi S, Montuori C, et al. Effectiveness of dupilumab in the treatment of patients with severe uncontrolled CRSwNP: a \u201creal-life\u201d observational study in the first year of treatment. J Clin Med 2022;11:2684. https:\/\/doi.org\/10.3390\/jcm11102684","DOI":"10.3390\/jcm11102684"},{"key":"10.14639\/0392-100X-N2841_ref16","doi-asserted-by":"crossref","unstructured":"Bachert C, Han JK, Wagenmann M, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management. J Allergy Clin Immunol 2021;147:29-36. https:\/\/doi.org\/10.1016\/j.jaci.2020.11.013","DOI":"10.1016\/j.jaci.2020.11.013"},{"key":"10.14639\/0392-100X-N2841_ref17","doi-asserted-by":"crossref","unstructured":"Gallo S, Russo F, Mozzanica F, et al. Prognostic value of the SinoNasal Outcome Test 22 (SNOT-22) in chronic rhinosinusitis. Acta Otorhinolaryngol Ital 2020;40:113-121. https:\/\/doi.org\/10.14639\/0392-100X-N0364","DOI":"10.14639\/0392-100X-N0364"},{"key":"10.14639\/0392-100X-N2841_ref18","doi-asserted-by":"crossref","unstructured":"De Corso E, Bellocchi G, de Benedetto M, et al. Biologics for severe uncontrolled chronic rhinosinusitis with nasal polyps: a change management approach. Consensus of the Joint Committee of Italian Society of Otorhinolaryngology on biologics in rhinology. Acta Otorhinolaryngol Ital 2022;42:1-16. https:\/\/doi.org\/10.14639\/0392-100X-N1614","DOI":"10.14639\/0392-100X-N1614"},{"key":"10.14639\/0392-100X-N2841_ref19","doi-asserted-by":"crossref","unstructured":"Pinkerton JW, Kim RY, Brown AC, et al. Relationship between type 2 cytokine and inflammasome responses in obesity-associated asthma. J Allergy Clin Immunol 2022;149:1270-1280. https:\/\/doi.org\/10.1016\/j.jaci.2021.10.003","DOI":"10.1016\/j.jaci.2021.10.003"},{"key":"10.14639\/0392-100X-N2841_ref20","doi-asserted-by":"crossref","unstructured":"Gibeon D, Batuwita K, Osmond M, et al. Obesity-associated severe asthma represents a distinct clinical phenotype: analysis of the British Thoracic Society Difficult Asthma Registry Patient cohort according to BMI. Chest 2013;143:406-414. https:\/\/doi.org\/10.1378\/chest.12-0872","DOI":"10.1378\/chest.12-0872"},{"key":"10.14639\/0392-100X-N2841_ref21","doi-asserted-by":"crossref","unstructured":"Nam JS, Roh YH, Fahad WA, et al. Association between obesity and chronic rhinosinusitis with nasal polyps: a national population-based study. BMJ Open 2021;11:E047230. https:\/\/doi.org\/10.1136\/bmjopen-2020-047230","DOI":"10.1136\/bmjopen-2020-047230"},{"key":"10.14639\/0392-100X-N2841_ref22","doi-asserted-by":"crossref","unstructured":"Mullol J, Bachert C, Amin N, et al. Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract 2022;10:1086-1095.e5. https:\/\/doi.org\/10.1016\/j.jaip.2021.09.037","DOI":"10.1016\/j.jaip.2021.09.037"},{"key":"10.14639\/0392-100X-N2841_ref23","doi-asserted-by":"crossref","unstructured":"Velluzzi F, Deledda A, Onida M, et al. Relationship between olfactory function and BMI in normal weight healthy subjects and patients with overweight or obesity. Nutrients 2022;14:1262. https:\/\/doi.org\/10.3390\/nu14061262","DOI":"10.3390\/nu14061262"},{"key":"10.14639\/0392-100X-N2841_ref24","doi-asserted-by":"crossref","unstructured":"Poessel M, Breuer N, Joshi A, et al. Reduced olfactory bulb volume in obesity and its relation to metabolic health status. Front Hum Neurosci 2020;14:586998. https:\/\/doi.org\/10.3389\/fnhum.2020.586998","DOI":"10.3389\/fnhum.2020.586998"},{"key":"10.14639\/0392-100X-N2841_ref25","doi-asserted-by":"crossref","unstructured":"Hummel T, Whitcroft K, Andrews P, et al. Position paper on olfactory dysfunction. Rhinology 2016;54:1-30. https:\/\/doi.org\/10.4193\/Rhino16.248","DOI":"10.4193\/Rhino16.248"}],"container-title":["Acta Otorhinolaryngologica Italica"],"original-title":[],"link":[{"URL":"https:\/\/www.actaitalica.it\/article\/view\/1132","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T08:05:58Z","timestamp":1742285158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.actaitalica.it\/article\/view\/1132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"URL":"https:\/\/doi.org\/10.14639\/0392-100x-n2841","relation":{},"ISSN":["1827-675X"],"issn-type":[{"value":"1827-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"article-number":"4"}}